Zanamivir Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza
Conditions:   Influenza;   Influenza, Human Interventions:   Drug: Drug: Oseltamivir;   Drug: Drug: Favipiravir;   Drug: Drug: Zanamivir;   Drug: Drug: Baloxavir;   Drug: Drug: Molnupiravir;   Drug: Drug: Peramivir;   Drug: Drug: Laninamivir Sponsor:   University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2022 Category: Research Source Type: clinical trials

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Zanamivir Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2021 Category: Research Source Type: clinical trials